Related Experiment Video
Updated: Feb 8, 2026

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
The human papilloma vaccine: A time for NP leadership
Robin L Hardwicke1, Laura J Benjamins, Richard M Grimes
1Robin L. Hardwicke is a professor of internal medicine and obstetrics/gynecology and reproductive medicine at the University of Texas Medical School at Houston, Houston, Tex. Laura J. Benjamins is an associate professor at the Department of Pediatrics, Division of Adolescent Medicine Center for Clinical Research and Evidence Based Medicine, the University of Texas Health Science Center at Houston, Houston, Tex. Richard M. Grimes is an adjunct professor at the Department of Internal Medicine, McGovern Medical School, University of Texas, Houston Health Science Center at Houston, Houston, Tex.
Abstract:
The human papilloma virus (HPV) causes approximately 30,700 annual cancer cases of the cervix, vulva, vagina, penis, oral cavity, and anus. Nurse practitioners can use their unique relationships with patients to advocate for the HPV vaccine. The purpose of this article is to update NPs on current knowledge regarding the HPV vaccine while providing appropriate information necessary for counseling patients and parents.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Mean free path and Mean free time
Mixing Time
Generation Time
Time Course of Drug Effect

